ACCENTIA BIOPHARMACEUTICALS INC Operating Expenses
ACCENTIA BIOPHARMACEUTICALS INC reported Operating Expenses of $12.82 million for the 12-month period ending 2012-09-30, per its 10-K filed 2012-12-26.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2012-12-26
- ACCENTIA BIOPHARMACEUTICALS INC operating expenses for the quarter ending 2012-09-30 was $2.65M, a 18.80% increase year-over-year.
- ACCENTIA BIOPHARMACEUTICALS INC operating expenses for the quarter ending 2012-06-30 was $2.35M, a 36.77% decline year-over-year.
- ACCENTIA BIOPHARMACEUTICALS INC operating expenses for the quarter ending 2012-03-31 was $5.84M, a 39.72% increase year-over-year.
- ACCENTIA BIOPHARMACEUTICALS INC operating expenses for the quarter ending 2011-12-31 was $1.99M, a 84.09% decline year-over-year.
- ACCENTIA BIOPHARMACEUTICALS INC operating expenses for fiscal 2012 was $12.82M, a 43.36% decline from fiscal 2011.
- ACCENTIA BIOPHARMACEUTICALS INC operating expenses for fiscal 2011 was $22.64M, a 273.62% increase from fiscal 2010.
- ACCENTIA BIOPHARMACEUTICALS INC operating expenses for fiscal 2010 was $6.06M.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month |
|---|---|---|---|---|---|---|
| 2012-09-30 | $2.65M derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-26 | $4.99M derived: sum of 2 quarters · filed 2012-12-26 | $10.83M derived: sum of 3 quarters · filed 2012-12-26 | $12.82M 10-K · filed 2012-12-26 | ||
| 2012-06-30 | $2.35M 10-Q · filed 2012-08-14 | $8.18M derived: sum of 2 quarters · filed 2012-08-14 | $10.18M 10-Q · filed 2012-08-14 | $12.40M derived: sum of 4 quarters · filed 2012-12-26 | ||
| 2012-03-31 | $5.84M 10-Q · filed 2012-05-15 | $7.83M 10-Q · filed 2012-05-15 | $10.06M derived: sum of 3 quarters · filed 2012-12-26 | $13.77M derived: sum of 4 quarters · filed 2012-12-26 | ||
| 2011-12-31 | $1.99M 10-Q · filed 2012-02-10 | $4.22M derived: sum of 2 quarters · filed 2012-12-26 | $7.93M derived: sum of 3 quarters · filed 2012-12-26 | $12.11M derived: sum of 4 quarters · filed 2012-12-26 | ||
| 2011-09-30 | $2.23M derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-26 | $5.94M derived: sum of 2 quarters · filed 2012-12-26 | $10.12M derived: sum of 3 quarters · filed 2012-12-26 | $22.64M 10-K · filed 2012-12-26 | ||
| 2011-06-30 | $3.71M 10-Q · filed 2012-08-14 | $3.92M 10-Q · filed 2011-08-12 | $7.89M derived: sum of 2 quarters · filed 2012-08-14 | $20.41M 10-Q · filed 2012-08-14 | $21.01M 10-Q · filed 2011-08-12 | $20.99M derived: sum of 4 quarters · filed 2012-08-14 |
| 2011-03-31 | $4.18M 10-Q · filed 2012-05-15 | $16.70M 10-Q · filed 2012-05-15 | $17.27M derived: sum of 3 quarters · filed 2012-05-15 | $18.89M derived: sum of 4 quarters · filed 2012-05-15 | ||
| 2010-12-31 | $12.52M 10-Q · filed 2012-02-10 | $13.10M derived: sum of 2 quarters · filed 2012-02-10 | $14.71M derived: sum of 3 quarters · filed 2012-02-10 | |||
| 2010-09-30 | $576.30K derived: 10-K 12 month − 10-Q 9 month · filed 2011-12-19 | $2.19M derived: sum of 2 quarters · filed 2011-12-19 | $6.06M 10-K · filed 2011-12-19 | |||
| 2010-06-30 | $1.62M 10-Q · filed 2011-08-12 | $5.48M 10-Q · filed 2011-08-12 |